|
Media Releases |
Financial Reports |
Presen-tations |
|
05/04/2006
|
|
|
|
| Lonza announces a worldwide price increase of 8-10% for Niacin and Niacinamide feed grade due to continued price increases of raw material and energy costs. |
The price increase will come into effect on 1 July 2006.
Lonza, a chemical and biotechnology company driven by the life sciences, generated sales of CHF 2.52 billion in 2005. Headquartered in Switzerland, Lonza operates 22 production and R&D sites around the world. Its 6300 employees are passionately committed to delivering sustainable value to their customers. Lonza is one of the leading custom manufacturers of chemical intermediates, active ingredients and biopharmaceuticals for the pharmaceutical and agrochemical industries. On the basis of organic and performance chemical and biotechnology platforms, Lonza creates value-added solutions for the nutrition, hygiene & personal care, wood & water treatment and industrial specialty markets. Lonza also offers polymer intermediates, resins and compounds. Lonza is listed on the SWX Swiss Exchange. Further information can be found on our website www.lonza.com.
For further information:
Ernesto Plozza
Business Unit Nutrition
Tel +41 61 316 8638
Fax +41 61 316 9638
ernesto.plozza@lonza.com
Margot Connor
Corporate Communications
Tel +41 61 316 8566
Fax +41 61 316 9566
Mobile +41 79 401 2832
margot.connor@lonza.com
|
|
|
